News/ News/ News/ Oncology/ Sales and Marketing Manufacturing foul-up hits Novartis’ radioligand business Phil Taylor Lutathera, manufacturing, Novartis, Oncology, Pluvicto, Radiopharmaceutical 0 Comment Novartis has shut down production of its radioligand therapies – one of its key growth areas – at Share X Manufacturing foul-up hits Novartis’ radioligand business https://pharmaphorum.com/news/manufacturing-foul-up-hits-novartis-radioligand-business/
Lutathera, manufacturing, Novartis, Oncology, Pluvicto, Radiopharmaceutical
0 Comment
